Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
DiaMedica Therapeutics, Inc. (DMAC) had Return on Equity of -22.70% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-7.71M |
|
-- |
|
-- |
|
$8.14M |
|
$-8.14M |
|
$0.44M |
|
$-7.70M |
|
$-7.70M |
|
$-7.71M |
|
$-7.71M |
|
$-7.71M |
|
$-7.71M |
|
$-8.14M |
|
$-8.39M |
|
42.84M |
|
42.84M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$37.42M |
|
$0.15M |
|
$1.41M |
|
$38.83M |
|
$4.67M |
|
$0.01M |
|
$0.21M |
|
$4.88M |
|
$33.95M |
|
$33.95M |
|
$33.95M |
|
42.86M |
|
| Cash Flow Statement Financials | |
$-7.15M |
|
$6.62M |
|
$0.09M |
|
$3.02M |
|
$2.59M |
|
$-0.44M |
|
$0.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.02 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-22.70% |
-22.70% |
|
-19.85% |
|
-22.69% |
|
$0.79 |
|
$-0.17 |
|
$-0.17 |
|